These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia. Ayyobi AF; Brunzell JD Am J Cardiol; 2003 Aug; 92(4A):27J-33J. PubMed ID: 12957324 [TBL] [Abstract][Full Text] [Related]
10. Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome. Venkatapuram S; Shannon RP Am J Ther; 2006; 13(1):64-71. PubMed ID: 16428924 [TBL] [Abstract][Full Text] [Related]
12. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome. Bestermann W; Houston MC; Basile J; Egan B; Ferrario CM; Lackland D; Hawkins RG; Reed J; Rogers P; Wise D; Moore MA Am J Med Sci; 2005 Jun; 329(6):292-305. PubMed ID: 15958871 [TBL] [Abstract][Full Text] [Related]
13. [The importance of syndrome X in daily practice]. Daubresse JC Rev Med Brux; 2000 Dec; 21(6):473-7. PubMed ID: 11194491 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of hypertension associated with diabetes mellitus]. Katayama S Nihon Rinsho; 1997 Aug; 55(8):2091-6. PubMed ID: 9284429 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiologic, diagnostic, and therapeutic aspects of the metabolic syndrome. Giles TD; Sander GE J Clin Hypertens (Greenwich); 2005 Nov; 7(11):669-78. PubMed ID: 16278525 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of hyperinsulinemia in polycystic ovary syndrome: what are the options? Ehrmann DA J Endocrinol Invest; 1998 Oct; 21(9):632-5. PubMed ID: 9856419 [No Abstract] [Full Text] [Related]
17. [Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects]. Demant T Fortschr Med Orig; 2001; 119(1):37-40. PubMed ID: 11935656 [TBL] [Abstract][Full Text] [Related]
19. Safety of drugs commonly used to treat hypertension, dyslipidemia, and Type 2 diabetes (the metabolic syndrome): part 2. Marcus AO Diabetes Technol Ther; 2000; 2(2):275-81. PubMed ID: 11469270 [TBL] [Abstract][Full Text] [Related]
20. The role of troglitazone in treating the insulin resistance syndrome. Granberry MC; Schneider EF; Fonseca VA Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]